Medisca has entered into a strategic partnership with dsm-firmenich which will make a portfolio of pharmaceutical-grade vitamin active pharmaceutical ingredients available to U.S. compounding professionals, expanding access to ingredients manufactured within European cGMP environments and supported by established quality systems and documentation standards.
The partnership reflects a long-term commitment to expanding access to high-quality ingredient solutions while preserving the workflows, relationships, and operational models customers rely on today. As compounding continues to support increasingly complex and regulated care settings, expectations around ingredient sourcing, consistency, and documentation continue to rise, with pharmacies and 503B outsourcing facilities seeking partners that enable them to operate with confidence at scale.
"We are grateful to partner with dsm-firmenich, a global organization recognized for its manufacturing standards and commitment to quality," said Peng Li, Vice President, Strategic Partnerships at Medisca. "Ingredient sourcing is foundational to trust and long-term success in compounding. By bringing dsm-firmenich pharmaceutical-grade API portfolio into the Medisca ecosystem, we are expanding what our customers can rely on today and supporting how the industry continues to evolve".
The partnership introduces pharmaceutical-grade vitamin APIs through an established commercial and technical model designed to support regulated use and long-term continuity across compounding practice.
Jennifer McManus, Senior Sales Director at dsm-firmenich, added: "Partnering with Medisca is a meaningful step in expanding access to high-quality, pharmaceutical-grade vitamin APIs for the U.S. compounding market. By combining our global manufacturing expertise and commitment to cGMP standards with Medisca's deep understanding of compounding professionals, we are strengthening supply reliability and enabling pharmacies and 503B outsourcing facilities to operate with greater confidence, consistency, and quality in patient care".
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!